Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in ST-elevation myocardial infarction undergoing primary PCI
IRCT20210423051047N2Phase 2Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jun 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in myocardial infarction (MI) and acute coronary syndrome (ACS) comparing Colchicine with Placebo (2 arms). Primary endpoint: Interleukin 1 beta level. Started Jun 2021; status: completed.
02
Drugs
colchicine
03
Conditions
myocardial infarction (MI)acute coronary syndrome (ACS)
Beyond the preview
Go deeper on IRCT20210423051047N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210423051047N2.